Bloomberg A Chinese biotech company which claimed to be able to manufacture an experimental drug from Gilead Sciences Inc with the potential to treat the novel coronavirus, was censured for disclosing inaccurate information. The Shanghai Stock Exchange said in an statement that BrightGene Bio-Medical Technology Co has not gained approval from China’s drug regulator to make the drug known as ...

Bloomberg Hong Kong will avoid the kind of property market crash that followed previous economic slumps in the finance hub, according to Financial Secretary Paul Chan. “We do not see the risk of an off-the-grid type of downfall,” Chan said in an interview on Monday with Bloomberg Television’s Yvonne Man. As Hong Kong’s economy reels from the coronavirus outbreak that ...

Bloomberg Masayoshi Son’s pitch to US hedge funds and financial institutions on the merits of SoftBank Group Corp just got harder, with a record market plunge that has made investors skittish and raised risks for its portfolio companies. The Japanese billionaire will be in New York for the first such meeting since the implosion of WeWork. In the months since, ...